MET Inhibition in Advanced NSCLC: Molecular Testing for METex14 and Emerging Options

Get up to date on testing for METex14 and incorporating selective MET inhibitors into the care of your patients with METex14-altered NSCLC with an on-demand Webcast and downloadable slides from a live Webinar video roundtables podcasts and expert-authored commentaries.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

This educational activity is supported by an independent grant from the Healthcare business of

Merck KGaA